NYSE 
NEW YORK, May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed
The average of price targets set by Wall Street analysts indicates a potential upside of 31.1% in...
West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which...
Why: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: ...
WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire ...
WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $226.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a ...
("West" or "the Company") (NYSE: WST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission ...
Janus Henderson Group PLC decreased its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) by 4.2% during the fourth quarter, according to the company in its most ...
West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) – Equities research analysts at Zacks Research boosted their Q2 2025 earnings estimates for shares of West Pharmaceutical Services ...
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf ...